European Pharmaceutical Review
SEPTEMBER 25, 2023
Key attributes of an enterprise resource planning (ERP) system required for drug traceability has been published in a Universal Journal of Pharmacy and Pharmacology paper. Specifically, it described how ERP systems clarify every aspect of operations in a business for drug serialisation compliance.
Pharmaceutical Representative Training
JANUARY 11, 2021
Pharmaceutical sales representatives (often times referred to as pharma reps) are hired by pharmaceutical/biotech companies to educate healthcare providers (HCPs) such as physicians, pharmacists, nurses, and physician assistants (PAs) on their company’s product. What skills are necessary to become a pharma sales rep?
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
pharmaphorum
AUGUST 16, 2022
The highly anticipated Lipid Nanoparticle Immunogenicity & Toxicity Summit takes place this December to unite 80+ senior leaders as the definitive meeting for clinical pharmacology , immunogenicity , bioanalytical development leaders to stay at the forefront, arming you with practical takeaways and lessons learned.
PM360
NOVEMBER 29, 2022
Drug labels hold value for life sciences companies because they are rich, extensive documents that can be used across labeling, regulatory, safety, and medical affairs. Example: Top Pharma Company Using NLP to Explore Drug Label Data. Food and Drug Administration (FDA) or European Medicines Agency (EMA).
pharmaphorum
SEPTEMBER 9, 2022
Digital health specialist Kry has teamed up with pharma group Novo Nordisk on the development of resources that can help people with obesity manage their condition and adhere to treatment. Novo Nordisk recently predicted its obesity sales could reach $3.7 billion in 2025.
Contrarian Sales Techniques
FEBRUARY 25, 2023
During my pharmacology class, I learned that there are no safe drugs, only safe patients. Clinical studies play an essential role in determining the safety and efficacy of new drugs before they can be approved for the public. This includes potential side effects or adverse reactions to medications.
pharmaphorum
DECEMBER 20, 2022
The road to the development of treatments for non-alcoholic steatohepatitis (NASH) is littered with failed projects, but US biotech Madrigal Pharma thinks it now has enough evidence for its drug resmetirom to support regulatory filings. Although, so far efforts to bring a therapy to market have failed.
Expert insights. Personalized for you.
94 
Let's personalize your content